varicella vaccine + DTaP vaccine

The combination of **varicella vaccine** and **DTaP vaccine** refers to the concurrent administration of two distinct pediatric immunizations. The varicella component is a live-attenuated vaccine, typically derived from the Oka strain of the Varicella-zoster virus, designed to elicit protective humoral and cellular immune responses against chickenpox. The DTaP component is a combination vaccine containing inactivated diphtheria and tetanus toxoids along with purified acellular pertussis antigens (such as pertussis toxoid, filamentous hemagglutinin, and pertactin). This combination provides active immunity against *Corynebacterium diphtheriae*, *Clostridium tetani*, *Bordetella pertussis*, and the Varicella-zoster virus. While these vaccines are frequently co-administered during the same clinical visit to adhere to pediatric immunization schedules (typically at 12-15 months and 4-6 years of age), they are currently supplied as separate products and administered via different routes (subcutaneous for varicella and intramuscular for DTaP). No single-vial formulation containing only these four components is currently approved for use.

Other names

varicella vaccine + DTaP vaccinechickenpox and DTaP vaccinesDTaP-Varicella co-administration